Diabetes Mellitus Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Diabetes Mellitus stocks.


Compare ETFs

      Diabetes Mellitus Stocks Recent News

      Date Stock Title
      Nov 21 TNDM Tandem Diabetes Care Announces Upcoming Conference Presentations
      Nov 21 CORT 3 Reasons Growth Investors Will Love Corcept (CORT)
      Nov 21 DXCM 3 US Stocks Estimated To Be Trading At Discounts Of Up To 39.3%
      Nov 21 PODD Insulet adds Abbott’s FreeStyle Libre 2 Plus to Omnipod 5’s compatibility roster
      Nov 21 PODD Insulet: Superb Business Growth, Starting Valuations Outsized Risk
      Nov 20 PODD Insulet Corporation: Significant Opportunities, Significant Threats - I'm On The Sidelines
      Nov 20 PODD Insulet's Omnipod 5 now compatible with Abbott's FreeStyle Libre 2 Plus
      Nov 20 CORT Wall Street Analysts Think Corcept (CORT) Could Surge 37.91%: Read This Before Placing a Bet
      Nov 20 PODD Insulet Announces Omnipod® 5 System is Now Compatible with Abbott’s FreeStyle Libre 2 Plus Sensor in the U.S.
      Nov 20 DXCM Dexcom invests $75M in Ōura, agrees to integrate smart rings and CGMs
      Nov 20 HALO Halozyme: Fabless Or Not, The Stock Is Now A Steal On Evotec Deal
      Nov 19 DXCM DexCom Pairs Its Glucose Monitor With ŌURA’s Smart Ring
      Nov 19 HALO 3 Reasons Why Growth Investors Shouldn't Overlook Halozyme Therapeutics (HALO)
      Nov 19 HALO HALO vs. FOLD: Which Stock Should Value Investors Buy Now?
      Nov 19 DXCM Dexcom invests $75m in ŌURA to forge partnership
      Nov 19 HALO Is Halozyme Therapeutics (HALO) a Great Value Stock Right Now?
      Nov 19 HALO Are Medical Stocks Lagging Cencora, Inc. (COR) This Year?
      Nov 19 DXCM DexCom to invest $75M in smart ring firm ŌURA
      Nov 19 DXCM Dexcom and ŌURA Announce Strategic Partnership
      Nov 18 HALO Halozyme Provides Update on Non-Binding Proposal to Combine with Evotec
      Diabetes Mellitus

      Diabetes mellitus (DM), commonly referred to as diabetes, is a group of metabolic disorders in which there are high blood sugar levels over a prolonged period. Symptoms of high blood sugar include frequent urination, increased thirst, and increased hunger. If left untreated, diabetes can cause many complications. Acute complications can include diabetic ketoacidosis, hyperosmolar hyperglycemic state, or death. Serious long-term complications include cardiovascular disease, stroke, chronic kidney disease, foot ulcers, and damage to the eyes.Diabetes is due to either the pancreas not producing enough insulin, or the cells of the body not responding properly to the insulin produced. There are three main types of diabetes mellitus:
      Type 1 DM results from the pancreas' failure to produce enough insulin due to loss of beta cells. This form was previously referred to as "insulin-dependent diabetes mellitus" (IDDM) or "juvenile diabetes". The cause is unknown.
      Type 2 DM begins with insulin resistance, a condition in which cells fail to respond to insulin properly. As the disease progresses, a lack of insulin may also develop. This form was previously referred to as "non insulin-dependent diabetes mellitus" (NIDDM) or "adult-onset diabetes". The most common cause is a combination of excessive body weight and insufficient exercise.
      Gestational diabetes is the third main form, and occurs when pregnant women without a previous history of diabetes develop high blood sugar levels.Prevention and treatment involve maintaining a healthy diet, regular physical exercise, a normal body weight, and avoiding use of tobacco. Control of blood pressure and maintaining proper foot care are important for people with the disease. Type 1 DM must be managed with insulin injections. Type 2 DM may be treated with medications with or without insulin. Insulin and some oral medications can cause low blood sugar. Weight loss surgery in those with obesity is sometimes an effective measure in those with type 2 DM. Gestational diabetes usually resolves after the birth of the baby.As of 2015, an estimated 415 million people had diabetes worldwide, with type 2 DM making up about 90% of the cases. This represents 8.3% of the adult population, with equal rates in both women and men. As of 2014, trends suggested the rate would continue to rise. Diabetes at least doubles a person's risk of early death. From 2012 to 2015, approximately 1.5 to 5.0 million deaths each year resulted from diabetes. The global economic cost of diabetes in 2014 was estimated to be US$612 billion. In the United States, diabetes cost $245 billion in 2012.

      Browse All Tags